Our findings suggest that topical treatment with GE, which partly rescues the ELOVL4 downregulation in psoriasis-like HPKs and increases the CERS3 expression, might contribute to the prevention and/or treatment of psoriasis. The gene discussed is ELOVL4; the disease is psoriasis.